Mangaluru: Close shave for newborn babies as warmer catches fire at NICU of Lady Goschen Hospital

Bengaluru, Jan 22: Three alleged Bangladeshi nationals living illegally in India were apprehended in Karnataka's Bengaluru district, police said on Wednesday.

The arrested are identified as Mohammed Lokman (55), his wife Jasmin Begun (35) and son Raasel (22) are natives of Boresel village in Pirojpur district in Bangladesh.

According to police, they were staying at a camp at Munnekolala village.

Mangaluru, Apr 29: District in-charge Minister Kota Srinivas Poojary on Wednesday inaugurated a mobile fever clinic to cure COVID-19 patients.

Karnataka State Road Transport Corporation (KSRTC) has converted one of its buses into a clinic in Mangaluru to treat COVID-19 patients.

The mobile fever clinic has a bed for the patient and a cabin for the doctor. There is also a seating facility, medicine box, wash-basin, sanitizer, soap oil, a separate water facility, and fans.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.